Speaker List 2016 Pegs Summit

2016 Archived Content

OVERVIEW | DOWNLOAD BROCHURE | SPEAKERS | SHORT COURSES

PEGS 2016 Speakers

Yasmina Abdiche, Ph.D., Research Fellow; Head, Bioanalytical Group, Rinat-Pfizer
Adam J. Adler, Ph.D., Professor, Immunology, School of Medicine, UConn Health
Mahiuddin Ahmed, Ph.D., Assistant Attending for Immunotherapies, Pediatrics, Memorial Sloan Kettering Cancer Center
Galit Alter, Ph.D., Associate Professor, Medicine; Kristine and Bob Higgins MGH Research Scholar; Director, Ragon Institute Imaging Core; Director, Harvard Center for Aids Research Immunology Core, Ragon Institute of MGH, MIT and Harvard
Christine Alves, Ph.D., Cell Culture Development, Biogen
Krista Alvin, MS, Associate Principal Scientist, Bioprocess Technology & Expression, Merck, Inc.
Jan Amstrup, Ph.D., Principal Scientist, CMC Bioassay, Novo Nordisk A/S
Peter A. Andreasen, Ph.D., Professor, Molecular Biology and Genetics, Aarhus University
Andreas Anton, Ph.D., Director, BioProcess Development, Wacker Biotech GmbH
Mehdi Arbabi Ghahroudi, Ph.D., Research Officer/Adjunct Professor, Human Health Therapeutics, National Research Council Canada
Michel Awwad, Ph.D., former Director, Pharmacokinetics & Dynamics & Metabolism, Merrimack Pharmaceuticals
Michael P. Bachmann, Ph.D., Professor, Helmholtz Zentrum Dresden Rossendorf (HZDR); Institute of Radiopharmaceutical Cancer Research, Radio-/Tumorimmunology
Joel Bard, Ph.D., Principal Research Scientist, Global Biotherapeutic Technologies, Pfizer
Gavin Barnard, Ph.D., Group Leader, Eli Lilly & Co.
Amrik Basran, Ph.D., CSO, Therapeutics, Avacta Life Sciences
Randal Bass, Ph.D., Vice President, Process Design, Just Biotherapeutics
Iris Batalha, Ph.D., Postdoctoral Research Associate, Chemical Engineering and Biotechnology, University of Cambridge
Jason Baum, Ph.D., Director and Diagnostic Project Lead, Companion Diagnostics, Merrimack Pharmaceuticals
Christine Beeton, Ph.D., Associate Professor, Molecular Physiology and Biophysics, Baylor College of Medicine
Dennis Benjamin, Ph.D., Vice President, Translational Research, Seattle Genetics, Inc.
Matthew J. Bernett, Ph.D., Senior Scientist, Protein & Antibody Engineering, Xencor, Inc.
Michael Blank, Ph.D., Co-Founder & CSO, Research & Development, AptaIT GmbH
John W. Blankenship, Ph.D., Lead Scientist, Molecular Biology and Protein Engineering, BioSciences Division, Emergent BioSolutions
Thomas Böldicke, Ph.D., Recombinant Protein Expression/Intrabody Unit, Helmholtz-Centre for Infection Research
Arden Bond, Staff Scientist, Analytical Development, Genzyme
Art Brace, Ph.D., Executive Director, Immuno-Oncology Research, Five Prime Therapeutics
Simon Brack, Ph.D., Director, Discovery Research, Covagen (one of the Janssen pharmaceutical companies of Johnson & Johnson)
Andrew M. Bradbury, M.D., Ph.D., Staff Scientist, Biosciences, Los Alamos National Laboratory
Philip E. Brandish, Ph.D., Principal Scientist, Immunology & Oncology, Merck Research Laboratories
Michael D. Brenowitz, Ph.D., Professor, Biochemistry, Albert Einstein School of Medicine
Jo Brewer, Ph.D., Director, Cell Research, Adaptimmune Ltd.
John S. Bridgeman, Ph.D., Director, Cell Therapy Research, Cellular Therapeutics Ltd.
Peter Bruenker, Ph.D., Area Head, Molecular Biology and Cell Line Engineering; Large Molecule Research, Roche Pharma Research and Early Development (pRED), Roche Glycart AG
Karen Bunting, Ph.D., Science Director, Molecular Biology & Fermentation, Albumedix Ltd.
Dennis R. Burton, Ph.D., Professor, Immunology and Microbial Science, Center for HIV/AIDS
Ross Chambers, Ph.D., Director, Antibody Discovery, Integral Molecular
Andrea Carfi, Ph.D., U.S. Head, Protein Biochemistry, GlaxoSmithKline Vaccines
Uwe Carl, Ph.D., Head, Protein Production, Strep-tag Products and Proteins, IBA GmbH
John F. Carpenter, Ph.D., Professor, Pharmaceutical Sciences; Co-Director, Center for Pharmaceutical Biotechnology, University of Colorado Anschutz Medical Center
Paul J. Carter, Ph.D., Senior Director and Staff Scientist, Antibody Engineering, Genentech
John Champagne, Senior Applications Scientist, Northeast Regional Manager, Wyatt Technology Corp.
Christine P. Chan, Ph.D., Principal Scientist and Technical Lead, Global Manufacturing Science and Technology, Genzyme - a SANOFI Company
Javier Chaparro-Riggers, Ph.D., Director, Antibody Technology, Rinat Pfizer, Inc.
Deborah Charych, Ph.D., Executive Director, Research Biology, Nektar Therapeutics
Janet Cheetham, Ph.D., Executive Director, Attribute Sciences Core Technologies, Amgen Inc.
Lei Chen, Ph.D., Senior Scientist, Global Biologics, Abbvie, Inc.
Kerry Chester, Ph.D., Professor, Molecular Medicine, University College London Cancer Institute
Narendra Chirmule, Owner & Principal, 7immune Consulting
André Choulika, Ph.D., CEO and Chairman, Cellectis
Daniel Christ, Ph.D., Associate Professor and Head, Antibody Therapeutics, Garvan Institute of Medical Research
Adam Clarke, Ph.D., Director, Lead Generation, Biologics, Teva Pharmaceuticals Australia
Steven Coats, Ph.D., Senior Director, R&D, MedImmune
Matthew Coleman, Ph.D., Senior Scientist, Physics and Life Sciences, Lawrence Livermore National Laboratory
Nick Conley, Ph.D., CEO, EpiBiome
Jim Cook, Immunology Sales Specialist, ProImmune
Carsten Corvey, Ph.D., Project Leader, Global Biotherapeutics, Sanofi-Aventis Deutschland GmbH
Ivan Correia, Ph.D., Research Fellow; Head, Global Protein Sciences, AbbVie Bioresearch Center
Kyra J. Cowan, Ph.D., Scientist, Genentech/Roche
Charles S. Craik, Ph.D., Professor, Pharmaceutical Chemistry, University of California, San Francisco
Carolyn Cuff, Ph.D., Leader, Translational Research & Investigation Unit, AbbVie Bioresearch Center, Inc.
Brendan D. Curti, M.D., Director, Genitourinary Oncology Research & Biotherapy Clinical Programs; Co-Director, Melanoma Program, Earle A. Chiles Research Institute, Providence Cancer Center
Katherine Cygnar, Ph.D., Staff Scientist, Genome Engineering Technologies, Regeneron Pharmaceuticals, Inc.
Daniel Daley, Ph.D., Associate Professor, Biochemistry & Biophysics, Stockholm University
Rick Davies, Ph.D., Associate Director, Reagents & Assay Development, AstraZeneca
Jonathan H. Davis, Ph.D., Principal Scientist, Protein Design, Bristol-Myers Squibb
Thomas Davis, M.D., CMO & Executive Vice President, Clinical Development, Celldex Therapeutics
Marc Damelin, Ph.D., Associate Director, Oncology Research Unit, Pfizer, Inc.
Mohammed M. Dar, M.D., Vice President, Clinical Development Oncology, MedImmune
Tapan Das, Ph.D., Director, Biologics Molecular and Analytical Development, Bristol-Myers Squibb
Gaël Debauve, Ph.D., Analytical Sciences for Biologicals - Bioassay Development Laboratory, UCB Pharma S.A., Braine-L’Alleud
Florian Deisenhammer, Ph.D., Clinical Department of Neurology, Innsbruck Medical University
Dharmesh Desai, Ph.D., Group Leader, Bristol-Meyers Squibb
Antonio DiGiadomenico, Ph.D., Scientist II, Infectious Diseases, MedImmune
Ina Dittler, Ph.D., Zurich University of Applied Sciences
Rakesh Dixit, Ph.D., DABT, Vice President, R&D; Global Head, Biologics Safety Assessment, Translational Sciences, MedImmune
Anaëlle Dos Santos, Head, Bioanalytics Unit, NovImmune SA
Michael Doyle, Ph.D., Senior Principal Scientist, Protein Science, Bristol-Myers Squibb
Zhimei Du, Ph.D., Senior Principal Scientist, Merck
Paurene Duramad, Ph.D., MPH, DABT, Drug Safety & Pharmacometrics, Regeneron Pharmaceuticals, Inc.
Ralph Eckenberg, Integrative Therapeutics, Dassault Systemes
Stephen J. Elledge, Ph.D., Gregor Mendel Professor, Genetics, Harvard Medical School; Division of Genetics, Brigham and Women’s Hospital; Investigator, Howard Hughes Medical Institute
Mark Ellis, Principal Scientist, UCB-New Medicines
Shelley Elvington, Ph.D., Technical Development Scientist, Genentech
Boris Engels, Ph.D., Investigator, Exploratory Immuno-Oncology, Novartis Institutes for Biomedical Research
Alan L. Epstein, M.D., Ph.D., Professor, Pathology, USC Keck School of Medicine
James Ernst, Ph.D., Senior Scientist, Therapeutic Proteins, Protein Chemistry, Genentech
James C. Errey, Ph.D., Associate Director, Protein Biochemistry, Heptares Therapeutics, Ltd.
Rachel Ettinger, Ph.D. Senior Scientist Respiratory, Inflammatory, and Autoimmune Diseases, MedImmune
Seth Ettenberg, Ph.D., CSO, Unum Therapeutics
Soldano Ferrone, M.D., Ph.D., Division of Surgical Oncology, Surgery, Massachusetts General Hospital
Dana Filoti, Ph.D., Senior Scientist, Protein Analytics, AbbVie
Nicolas Fischer, Ph.D., Head, Research, Novimmune SA
Sally Fischer, Ph.D., Principal Scientist, Development Sciences, Genentech
Simon Fischer, Ph.D., Scientist, BP Process Development Germany, Boehringer Ingelheim Pharma GmbH & Co. KG
Joan Foster, Field Application Scientist, R&D, MaxCyte
Arnaud Foussat, Ph.D., CSO, TxCell
Jim Freeth, Ph.D., Managing Director, Retrogenix Ltd.
Michael Gallo, President, Research, Innovative Targeting Solutions
Tara C. Gangadhar, M.D., Assistant Professor, Medicine, Hematology-Oncology Division, Abramson Cancer Center of the University of Pennsylvania
Elaina Gartner, M.D., Medical Director, Experimental Medicine, Seattle Genetics, Inc.
John Gebler, Ph.D., Director, Biopharma Business Development, Waters Corporation
Raja Ghosh, Ph.D., Professor, Chemical Engineering, McMaster University
David Gilham, Ph.D., Senior Lecturer, Clinical and Experimental Immunotherapy Group; ICS PGR Director, Institute of Cancer Sciences, University of Manchester
Pierre-Alain Girod, Ph.D., CSO, Selexis, SA
Jacob Glanville, CSO, Distributed Bio Inc
Anton Glieder, Ph.D., Professor, Molecular Biotechnology, Graz University of Technology
David M. Goldenberg, Sc.D., M.D., CSO and Chairman, Immunomedics, Inc.
Torbjorn Gräslund, Ph.D., Staff, Division of Protein Technology, School of Biotechnology, KTH Royal Institute of Technology and Affibody
Flaviu Gruia, Ph.D., Scientist, Analytical Biotechnology, MedImmune
Jianxin Guo, Ph.D., Principal Scientist, Pfizer
Claes Gustafsson, Chief Commercial Officer, DNA2.0, Inc.
William Hallett, Ph.D., Product Quality & Immunogenicity Reviewer, CDER/OPQ/OBP, FDA
Haruki Hasegawa, Ph.D., Principal Scientist, Therapeutic Discovery, Amgen, Inc.
John Haurum, M.D., CEO, F-star GmbH & F-star Biotechnology Ltd.
Jesse C. Hay, Ph.D., Professor, Division of Biological Sciences, University of Montana
Ronald Herbst, Ph.D., Vice President and Head, Oncology Research, MedImmune
Oliver Hill, Ph.D., Vice President, Molecular Biology, Apogenix, GmbH
Mitchell Ho, Ph.D., Chief, Antibody Therapy Section, Laboratory of Molecular Biology, National Cancer Institute, NIH
F. Stephen Hodi, M.D., Associate Professor, Medicine, Medical Oncology, Dana-Farber Cancer Institute
Isidro Hotzel, Ph.D., Senior Scientist, Antibody Engineering, Genentech, a member of the Roche Group
Walter Hoyer, Ph.D., Principal Statistician, TD Statistics & Mathematical Modelling, Novartis Vaccines and Diagnostics GmbH
Jenny Hu, Scientist, Bioanalytical Science, PKDM, Amgen
Ian Hunt, Ph.D., Group Leader, Protein Sciences, Novartis
Musaddeq Hussain, Ph.D., Principal Scientist, BioProcess Development, Biologics and Vaccines Research, Merck Research Laboratories
Michael Hust, Ph.D., Group Leader, Institut für Biochemie, Biotechnologie und Bioinformatik, Technische Universität Braunschweig
Peter Hwang, Ph.D., Assistant Professor, Biochemistry, University of Alberta
Roxana Iacob, Ph.D., Research Assistant Professor, Northeastern University
Shinya Ishii, Ph.D., Research Scientist, Discovery Research, Chugai Pharmaceutical Co., Ltd.
Andrea Itano, Ph.D., Vice President, Head of Tempero Discovery Performance Unit, Immuno-Inflammation, GlaxoSmithKline
Donald Jacobs, Ph.D., Professor, Physics and Optical Science, University of North Carolina
Vaibhav Jadhav, Ph.D., Scientist, Austrian Centre of Industrial Biotechnology, ACIB
Bent K. Jakobsen, Ph.D., FMedSci, CSO, Immunocore Ltd.
Vibha Jawa, Ph.D., Principal Scientist, Clinical Immunology, Amgen, Inc.
Michael C. Jensen, M.D., Professor, Pediatrics; Adjunct Professor, Bioengineering, University of Washington School of Medicine; Director, Ben Towne Center for Childhood Cancer Research, Seattle Children’s Research Institute; Joint Member, Program in Immunology, Fred Hutchinson Cancer Research Center
Janne Johansson, Ph.D., Professor, Neurobiology, Care Sciences and Society, Karolinska Institutet Center for Alzheimer Research, Novum
Syd Johnson, Ph.D., Vice President, Antibody Engineering, MacroGenics, Inc.
Denise Karaoglu Hanzatian, Ph.D., Principal Research Scientist, AbbVie Bioresearch Center
Molly Karlinsey, Ph.D., Investigator, Bioanalysis, GlaxoSmithKline
Hubert Kettenberger, Ph.D., Senior Principal Scientist, Protein Analytics, Roche Pharma Research & Early Development, Roche Innovation Center Penzberg
Kimberly Kelly, Ph.D., Associate Professor, Biomedical Engineering, Robert M. Berne Cardiovascular Research Center, University of Virginia
Javed Khan, M.D., Deputy Chief, Genetics Branch; Senior Investigator, Head, Oncogenomics Section, National Cancer Institute
Bharat Khurana, DVM, Ph.D, MBA, Microbiologist, Division of Vaccines, FDA/CBER/OVRR/DVRPA
Michelle Kinder, Ph.D., Scientist Immuno-Oncology Discovery, Janssen Research & Development, LLC
Niamh Kinsella, Principal Consultant, Vice President, Early Stage Product Development, NDA Regulatory Science Ltd.
Eloi P. Kpamegan, Ph.D., MSF, Executive Director, Clinical & Nonclinical Biostatistics, Novavax, Inc.
Christopher Landowski, Ph.D., Senior Research Scientist, Industrial Biotechnology, VTT Technical Research Centre of Finland, Ltd.
Thomas Oliver Kleen, Ph.D., Executive Vice President, Immune Monitoring, Epiontis GmbH
Neeraj Kohli, Ph.D., Associate Director, Discovery, Merrimack Pharmaceuticals
Prabuddha K. Kundu, Ph.D., Executive Director, Premas Biotech Pvt Ltd.
Hyung-Kwon Lim, Ph.D., Senior Research Scientist, Antibody Engineering, MOGAM Biotechnology Institute
Timothy K. Lu, M.D., Ph.D., Assistant Professor, Biological & Electrical Engineering, Massachusetts Institute of Technology (MIT)
J. Louise Lines, Research Scientist, Microbiology & Immunology, Dartmouth College
Mika Kamata-Sakurai, Ph.D., Scientist, Discovery Research, Research Division, Chugai Pharmaceutical Co., Ltd.
Farrah Kheradmand, M.D., Professor, Pathology and Immunology, Baylor College of Medicine
Kei Kishimoto, Ph.D., CSO, Selecta Biosciences
Uday Kishore, Ph.D., Director, Center for Infection, Immunity and Disease Mechanisms, Brunel University
Christopher A. Klebanoff, M.D., Assistant Clinical Investigator, Center for Cancer Research, National Cancer Institute
Holbrook E.K. Kohrt, M.D., Ph.D., Assistant Professor, Medicine, Divisions of Hematology and Oncology, Center for Clinical Sciences Research, Stanford University Cancer Institute
Harald Kolmar, Ph.D., Professor & Head, Biochemistry, Technical University of Darmstadt
Manfred Konrad, Ph.D., Research Director, Enzyme Biochemistry, Max Planck Institute for Biophysical Chemistry
Richard S. Kornbluth, M.D., Ph.D., President & CSO, Multimeric Biotherapeutics, Inc.
Holbrook Kohrt, Ph.D., Assistant Professor, Medicine, Stanford University
Atanas Koulov, Ph.D., Group Head, Senior Principal Scientist, Pharma Technical Development Europe (Biologics) Analytics, F. Hoffmann-La Roche Ltd., Switzerland
David M. Kranz, Ph.D., Phillip A. Sharp Professor, Biochemistry, University of Illinois
Christos Kyratsous, Ph.D., Senior Staff Scientist, Infectious Diseases, Regeneron Pharmaceuticals, Inc.
Michelle Krogsgaard, Ph.D., Assistant Professor, New York University School of Medicine
Prabuddha K. Kundu, Ph.D., Executive Director, Premas Biotech Pvt Ltd.
Joshua LaBaer, M.D., Ph.D., Director, Virginia G. Piper Center for Personalized Diagnostics, The Biodesign Institute, Arizona State University
Simon Lacey, Ph.D., Director, Translational and Correlative Studies Laboratory, Product Development and Correlative Sciences, University of Pennsylvania
David Laidlaw, CEO, Kuhner Shaker, Inc.
Chia-Ying K. Lam, Ph.D., Scientist II, Antibody Engineering, MacroGenics, Inc.
John Lambert, Ph.D., Executive Vice President, Research, and Distinguished Research Fellow, ImmunoGen, Inc.
Deborah Law, D. Phil., CSO Jounce Therapeutics, Inc.
Amy S. Lee, Ph.D., Professor, Biochemistry & Molecular Biology, Keck School of Medicine of University of Southern California, USC Norris Comprehensive Cancer Center
Benhur Lee, M.D., Professor and Ward-Coleman Chair, Microbiology, Icahn School of Medicine, Mount Sinai
Daniel W. “Trey” Lee, M.D., Assistant Clinical Investigator, St. Baldrick’s Scholar, Pediatric Oncology Branch, National Cancer Institute
Emily Leproust, Ph.D., CEO, Twist Bioscience
Gail Lewis Phillips, Ph.D., Senior Scientist, Molecular Oncology, Genentech
Han Li, Ph.D., Principal Scientist, Leads Discovery and Optimization, Bristol-Myers Squibb
John Li, Ph.D., Scientist, MedImmune
Chrystal Louis, Ph.D., Co-Director, Neuroblastoma Program, Texas Children’s Hospital; Assistant Professor, Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Israel Lowy, M.D., Ph.D., Vice President and Head, Translational Science and Oncology, Regeneron
J. Louise Lines, Research Scientist, Microbiology & Immunology, Dartmouth College
David R. Liu, Ph.D., Professor, Chemistry & Chemical Biology, Harvard University
Irene Liu, Ph.D., Associate Scientist, Cell Line Development, Pre-Pivotal Drug Substance-PD, Amgen, Inc.
Jie Liu, M.D., Ph.D., Senior Scientist, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University
Brian Long, Ph.D., Senior Scientist, Immunology Assessment, BioMarin
Hua Long, Senior Principal Scientist, Pfizer
LiNa Loo, Ph.D., Senior Scientist, Bioanalytical Development, Merck
James Love, Ph.D., Director, Technology Development, Biochemistry, Albert Einstein College of Medicine
Lawrence G. Lum, M.D., D.Sc., Professor, Oncology and Immunology & Microbiology; Scientific Director, BMT; Director, Immunotherapy, Karmanos Cancer Institute Wayne State University
Yin Luo, Ph.D., Associate Research Fellow, Analytical Research & Development, BTxPS, Pfizer
Robert Mabry, Ph.D., Director, Protein Sciences and Antibody Technology, Jounce Therapeutics
Tony Manning, Ph.D., Vice President, Research, Momenta Pharmaceuticals
Jim McNally, Ph.D., Associate Director, QPD Program Representative and Immunogenicity Expert, EMD Serono, Inc.
Giovanni Magistrelli, Ph.D., Head, Protein Engineering, NovImmune SA
Hanns-Christian Mahler, Ph.D., Head, Drug Product Services, Lonza AG
Haripada Maity, Ph.D., Research Advisor, Formulation Development, Eli Lilly and Company
Chuanbin Mao, Ph.D., George Lynn Cross Research Professor, Chemistry & Biochemistry; Member, Peggy and Charles Stephenson Cancer Center, University of Oklahoma
Alex Marson, Ph.D., UCSF Sandler Fellow, University California, San Francisco
William M. Matousek, Ph.D., Staff Scientist, Protein Biochemistry Preclinical Development, Regeneron Pharmaceuticals, Inc.
Marcela V. Maus, M.D., Ph.D., Director, Cellular Immunotherapy, Mass General Hospital Cancer Center
Sean McClain, CEO and Founder, AbSci
Patrick J. McEnaney, Ph.D., Postdoctoral Researcher, Departments of Cancer Biology and Chemistry, The Scripps Research Institute Florida
Michaela Mehler, Doctoral Researcher, Biophysical Chemistry, JW Goethe University
Russ Mcsweeney, Automation Sales Specialist, Beckman Coulter Life Sciences
Erik Meyer, Ph.D., Senior Scientist, GlaxoSmithKline
Ralph R. Minter, Ph.D., Fellow, Antibody Discovery and Protein Engineering, MedImmune Ltd.
Shahram Misaghi, Ph.D., Scientist, Early Stage Cell Culture, Genentech, a member of the Roche Group
Vera Molkenthin, Ph.D., Chief Scientist, AbCheck
Charles Morris, MBChB, MRCP(UK), Chief Development Officer, ImmunoGen
Philipp Müller, Ph.D., Head, Cancer Immunology & Immunotherapy Laboratory, Department of Biomedicine (DBM), University Hospital and University of Basel
Horacio G. Nastri, Ph.D., Senior Director, Antibody Biotherapeutics, Incyte Corporation
David Nicoli, Ph.D., Vice-President, Research & Development, Particle Sizing Systems
Li Niu, Ph.D., Chemistry Department, Center for Neuroscience Research, University at Albany, SUNY
Brian M Olson, Ph.D., Assistant Scientist, University of Wisconsin Carbone Cancer Center
Shane Olwill, Vice President, Head, Development, Pieris Pharmaceuticals Inc
Rene Pagila, Scientist Group Leader, Aragen Bioscience
Jagroop Pandhal, Ph.D., Lecturer, Biological Engineering, Chemical and Biological Engineering, The University of Sheffield
Babita Parekh, Ph.D., Director, Bioanalytical Science, Eli Lilly and Company
Ira Pastan, M.D., Co-Chief, Molecular Biology, National Cancer Institute, National Institutes of Health
Jian Payandeh, Ph.D., Scientist, Structural Biology, Genentech
David Pearlman, Ph.D., Senior Principal Scientist, Schrödinger
Gisela Peraus, Ph.D., Investigator II, DMPK, Novartis Institutes for Biomedical Research
Britta Person-Skegro, Ph.D., Project Manager & Scientific Operations, Biopharmaceutical Analysis, Solvias
Oxana Pester, Ph.D., Manager, Development Analytics, Pharma Technical Development Analytics, Roche Diagnostics GmbH
Deborah Phippard, Ph.D., Vice President, Research, Precision for Medicine
Shari Pilon-Thomas, Ph.D., Research Scientist, Translational Science, Moffitt Cancer Center
Robert Pordy, M.D., FACP, Vice President, Cardiovascular & Metabolism Therapeutics, Regeneron Pharmaceuticals
Alpana Prasad, Product Manager, iCE Marketing, ProteinSimple
David Rabuka, Global Head, Research & Development, Chemical Biology, Catalent Pharma Solutions
Laszlo G. Radvanyi, Ph.D., CSO, Lion Biotechnologies
Jack A. Ragheb, M.D., Ph.D., Chief Medical Research Officer, Office of Biological Products, CDER/FDA; Attending Physician, Warren Grant Magnuson Clinical Center, NIH
G. Jonah Rainey, Ph.D., Senior Scientist, ADPE, MedImmune, LLC
Manoj Rajadhyaska, Ph.D., Director, Bioanalytical Sciences, Regeneron Pharmaceuticals Inc.
Rahul Rajan, Ph.D., Director and Functional Area Head, Drug Product Formulation, Amgen, Inc.
Alexander Rakhmilevich, M.D., Ph.D., Distinguished Senior Scientist, University of Wisconsin-Madison
Sridhar Ramaswamy, M.D., Associate Professor, Medicine, Massachusetts General Hospital Cancer Center, Broad Institute, Harvard University and MIT
Sai Reddy, Ph.D., Assistant Professor, Biosystems Science and Engineering, ETH, Zurich, Switzerland
Wayne F. Reed, Ph.D., Professor, Physics; Founding Director, PolyRMC, Tulane University
Janice M. Reichert, Ph.D., Managing Director, Reichert Biotechnology Consulting LLC
Yoram Reiter, Ph.D., Professor & Head, Laboratory of Molecular Immunology, Technion-Israel Institute of Technology
Jörg T. Regula, Ph.D., Head, Protein Analytics, Roche Diagnostics GmbH
Leonard Reyno, M.D., Senior Vice President & CMO, Agensys
Alan Rigby, Ph.D., CSO and Senior Vice President, Synta Pharmaceutic
Theo Rispens, Ph.D., Senior Scientist, Immunopathology, Sanquin
Christopher J. Roberts, Ph.D., Associate Professor, Chemical & Biomolecular Engineering, University of Delaware
Thomas Rohrer, Senior Manager, Antibody Drug Conjugation Project Evaluation, Lonza
William G. Romanow, Senior Associate Scientist, Protein Technologies, Amgen, Inc.
Robert Roth, Ph.D., Associate Principle Scientist, Reagents and Assay Development, Discovery Sciences iMed, AstraZeneca
Richard Rustandi, Ph.D., Principal Scientist, Vaccine Analytical Development, Merck Research Labs
Abhi Saharia, Ph.D., Director, Cell-based Assays & Biologics, DiscoverX Corporation
Laura I. Salazar-Fontana, Ph.D., Strategic Advisor for Immunology and Biomarkers, Sanofi R&D
Puja Sapra, Ph.D., Senior Director, Bioconjugates Discovery & Development, Pfizer, Inc.
Aaron K. Sato, Ph.D., Vice President, Research, Sutro Biopharma
Andreas Schaaf, Ph.D., CSO, R&D, Greenovation Biotech GmbH
Peggy Scherle, Ph.D., Vice President, Preclinical Pharmacology, Incyte Corporation
Oliver Schlenker, Ph.D., Senior Research Scientist, Protein Engineering, Heptares Therapeutics, Ltd.
Tilman Schlothauer, Ph.D., Principal Scientist, Large Molecule Research, Roche Innovation Center
Jonathan Schneck, Ph.D., M.D., Professor, Pathology, Medicine and Oncology, Johns Hopkins
Julia Schuette, Ph.D., Head, Marketing and Sales, Biametrics GmbH
Richard Schwartz, Ph.D., Chief, Vaccine Production Program Lab, NIAID, NIH
Alexander N. Shoushtari, M.D., Medical Oncologist, Memorial Sloan Kettering Cancer Center
Andrew K. Sewell, Ph.D., Distinguished Research Professor, Wellcome Trust Senior Investigator; Research Director, Institute of Infection and Immunity, Henry Wellcome Building, Cardiff University School of Medicine
Charles Sentman, Ph.D., Professor, Microbiology & Immunology; Director, Center for Synthetic Immunity, The Geisel School of Medicine at Dartmouth
Vikas Sharma, Ph.D., Senior Group Leader and Senior Scientist, Late Stage Pharmaceutical Development, Genentech
Whitney Shatz, MS, Senior Scientific Researcher, Genentech
Jeffrey Siegel, M.D., Senior Group Medical Director, Product Development Immunology, Genentech
Eric V. Shusta, Ph.D., Howard Curler Distinguished Professor, Chemical and Biological Engineering, University of Wisconsin-Madison
Sachdev Sidhu, Ph.D., Professor, Molecular Genetics, University of Toronto
Satish Singh, Ph.D., Research Fellow and Group Leader, Pfizer
Andrew D. Skora, Ph.D., Postdoctoral Fellow, Ludwig Center for Cancer Genetics and Therapeutics, Johns Hopkins Kimmel Cancer Center
Darrell Sleep, Ph.D., CSO, Albumedix Ltd.
Eric Smith, Ph.D., Associate Director, Bispecifics, Regeneron Pharmaceuticals
Ernest S. Smith, Ph.D., Senior Vice President, Research & CSO, Vaccinex, Inc.
Arjan Sniyder, Ph.D., Associate Principal Scientist, AstraZeneca Discovery R&D
Rainer Stahn, Ph.D., Head, Clone Development, Upstream Process Development and PTM Analytics, Glycotope GmbH
Gerald Striedner, Ph.D., Assistant Professor, Biotechnology, University of Natural Resources and Life Sciences, Vienna
Byeong Doo Song, Ph.D., President, Scripps Korea Antibody Institute
Yifan Song, Ph.D., CSO, Cyrus Biotechnology
Ryan Stafford, Ph.D., Associate Director, Protein Engineering, Sutro Biopharma, Inc.
Yvette Stallwood, Ph.D., Head, Applied Protein Services, Lonza Biologics
Leonidas Stamatatos, Ph.D., Member, Vaccine and Infectious Disease Division, Immunology and Vaccine Development Program, Fred Hutchinson Cancer Research Center
Robert B. Stein, M.D., Ph.D., CSO, Agenus
Randy B. Stockbridge, Ph.D., Biochemistry, Brandeis University
Anna Stradner, Ph.D., Associate Professor, Physical Chemistry, Lund University
Meena Subramanyam, Ph.D., Vice President, Global Biomarker Product Safety, Biogen
Chris Suh, Ph.D., Business Development Manager, PhyNexus, Inc.
Shantanu Sule, Ph.D., Senior Engineer, Parenteral Drug Product Development, Biogen
Trevor Swartz, Ph.D., Senior Scientist, Early Stage Pharmaceutical Development, Genentech
Jeonghoon Sun, Ph.D., Principal Scientist, Biotherapeutics, Celgene Corporation
Mohammad Tabrizi, Ph.D., Senior Fellow and Head, PKPD, Merck
Liang Tang, Ph.D., Senior Scientist and Group Head, Molecular Biology and Protein Expression, Global Biologic Research, Global Drug Discovery, Bayer HealthCare
Beverly A. Teicher, Ph.D., Chief, Molecular Pharmacology Branch, National Cancer Institute
Peter M. Tessier, Ph.D., Associate Professor, Chemical & Biological Engineering, Rensselaer Polytechnic Institute
Lena Thoring, Bioanalytics and Bioprocesses, Fraunhofer Institute for Cell Therapy and Immunology (IZI)
Nels Thorsteinson, Scientific Services Manager, Biologics, Chemical Computing Group
Mark Throsby, Ph.D., CSO, Merus
Alain C. Tissot, Ph.D., Head, Immune Biology, Large Molecule Research, Roche Pharma Research & Early Development, Roche Innovation Center Penzberg, Roche Diagnostics GmbH, Switzerland
Michael G. Tovey, Ph.D., INSERM Director, Research, Laboratory of Biotechnology & Applied Pharmacology, Ecole Normale Supérieure de Cachan
Pamela Trail, Ph.D., Vice President, Oncology, Regeneron Pharmaceuticals
Kristopher Truncali, Scientist, Mass Spectrometry, Boehringer Ingelheim Pharmaceuticals
Hua Tu, Ph.D., Chairman and CEO, LakePharma, Inc.
Christopher D. Turner, M.D., Vice President, Clinical Science, Celldex Therapeutics, Inc.
David Urech, Ph.D., CSO and Co-CEO, Numab AG
Stefanie Urlinger, Ph.D., Director, R&D, MorphoSys AG
PJ Utz, M.D., Professor, Immunology and Rheumatology, Stanford University School of Medicine
David Veesler, Ph.D., Assistant Professor, Department of Biochemistry, University of Washington
Petter Veiby, Ph.D., Global Head, Biotherapeutics, Oncology Drug Discovery Unit, Takeda Pharmaceuticals International
Thomas A. Waldmann, M.D., Co-Chief, Lymphoid Malignancies Branch; Senior Investigator, Head, Cytokine Immunology and Immunotherapy Section, Center for Cancer Research, National Cancer Institute
Geoffrey Waldo, Ph.D., Research Scientist Level 4, HRL, Los Alamos National Labs
Roland B. Walter, M.D., Ph.D., MS, Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center; Associate Professor, Medicine, Medicine/Division of Hematology, University of Washington
Robert Walters, Ph.D., Senior Scientist, Pfizer
Ying-Kai Wang, Ph.D., Senior Research Investigator, Lead Discovery and Optimization, Bristol-Myers Squibb
Andrew D. Weinberg, Ph.D., Chief, Laboratory of Basic Immunology, Providence Cancer Center; Agonox, Inc.
Maria Wendt, Ph.D., Head , Science, Genedata
Timothy Whitehead, Ph.D., Assistant Professor, Chemical Engineering and Materials Science, Michigan State University
Max S. Wicha, M.D., Madeline and Sidney Forbes Professor, Oncology; Founding Director Emeritus, University of Michigan Comprehensive Cancer Center
Krista Witte, Ph.D., Vice President, Product Development, Unchained Labs
Michael Wittekind, Ph.D., Senior Vice President of Research and CSO, ContraFect Corp.
K. Dane Wittrup, Ph.D., J.R. Mares Professor, Chemical Engineering & Bioengineering, Massachusetts Institute of Technology
Melissa Wojcik, Sr. Associate Scientist, Analytical Development, Histogenics Corp. (Contractor)
Wen Jin Wu, Ph.D., Senior Investigator, Office of Biotechnology Products, CDER, US FDA
Yuling Wu, Ph.D., Principal Scientist, Clinical Pharmacology & DMPK, Translational Sciences, MedImmune
Kai W. Wucherpfennig, M.D., Ph.D., Professor, Dana-Farber Cancer Institute and Harvard Medical School
Christopher van der Walle, Ph.D., Principal Scientist, MedImmune
James A. Van Deventer, Ph.D., Assistant Professor, Chemical and Biological Engineering, Tufts University
Wouter Verdurmen, Ph.D., Postdoctoral Fellow, Biochemistry, University of Zurich
Malene Bech Vester-Christensen, Ph.D., Senior Scientist, Recombinant Expression Technologies, Novo Nordisk A/S
Harry Yang, Ph.D., Senior Director R&D, Medimmune, LLC
Jihong Yang, Ph.D., Senior Scientist, Bioanalytical Sciences, Genentech
Weifeng Xu, Ph.D., Senior Research Investigator, BAS-Biologics, Bristol-Myers Squibb
Camellia Zamiri, Ph.D., Scientist, Late Stage Pharmaceutical Development, Genentech
William C. Zamboni, Pharm.D., Ph.D., Associate Professor and Director, Translational Oncology and Nanoparticle Drug Development Initiative (TOND2I) Lab, The University of North Carolina
Ali Zarrin, Ph.D., Scientist, Immunology, Genentech
Qi Zeng, Ph.D., Research Director and Professor, Institute of Molecular and Cellular Biology, A*STAR
Jad Zoghbi, Senior Scientist, Sanofi (Genzyme)
Jiang Zhu, Ph.D., Assistant Professor, Immunology & Microbial Science, Scripps Research Institute
Yao Zhuang, Ph.D., Principal Scientist, PKDM Bioanalytical Sciences, Amgen
Gerhard Zugmaier, M.D., Professor, Internal Medicine, Hematology/Oncology, Marburg University; Executive Medical Director, Global Development, Amgen Research Munich